GlassScriptPhysician profile
Steven A Gelber
NPI 1619047180
$2,270.78
in general payments reported to CMS, 2019-2025
24 companies · $44.77 in 2025
The $44.77 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $279 · 2021: $152 · 2022: $535 · 2023: $353 · 2024: $161 · 2025: $44.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $761.60 | 2019-2023 | |
| Coopersurgical, INC. | $224.10 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $175.34 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $172.06 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $164.83 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $131.14 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $110.00 | 2020 | |
| Lupin INC. | $64.02 | 2019 | |
| Myovant Sciences INC. | $63.93 | 2022 | |
| Therapeuticsmd, INC. | $57.47 | 2019-2022 | |
| Organon LLC | $52.57 | 2021-2023 | Nexplanon |
| Axonics, INC. | $37.12 | 2024 | Bulkamid |
| Boston Scientific Corporation | $28.37 | 2025 | Bulkamid |
| Exeltis, USA INC. | $28.23 | 2023 | Slynd |
| Ge Healthcare | $27.21 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $25.59 | 2019-2021 | |
| Meditrina | $25.30 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $23.82 | 2023 | Exparel |
| Amag Pharmaceuticals, INC. | $18.58 | 2019 | |
| Allergan, INC. | $17.69 | 2019 | |
| Astellas Pharma US INC | $17.62 | 2024 | Veozah |
| Idorsia Pharmaceuticals US INC | $16.88 | 2022 | |
| Z-Medica, LLC | $15.75 | 2019 | |
| Baxter Healthcare | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Gelber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.